Zoetis is accepting grant proposals for research into innovative approaches to help protect cattle, dogs, sheep and poultry from parasitic diseases and to extend the efficacy of therapeutics through new formulations.

Through a grant awards program, Zoetis will award a minimum of $25,000 and maximum of $150,000 to support each selected grant proposal. More than one grant may be awarded.

“We at Zoetis are interested in advancing novel approaches to protect animals from parasitic diseases, to improve the health and productivity of livestock animals and to help companion animals live longer, healthier lives,” said Debra Woods, research director and head of Parasitology Global Therapeutics Research for Zoetis. “Through this grant program, we aim to energize investigation into anti-parasitic therapeutics research and advance science in this area of high need in animal health.”

In cattle and sheep, Zoetis is seeking proposals that explore approaches to protect cattle and sheep from endoparasites, in particular to control resistant nematodes and trematodes and to prevent cryptosporidiosis.

Zoetis wants proposals focused on helping to protect dogs from heartworm disease by taking novel biological or biopharmaceutical approaches to prevention and on developing diagnostic tools to detect the early stages of infection. Projects might also look at understanding early stages of heartworm infection, including the mechanisms of their migration through the tissues to the heart.

Proposals in poultry should look at new approaches to control coccidiosis.

Zoetis is also seeking proposals that could extend the duration of efficacy of active ingredients using persistent formulations.

To apply, download and complete the application form at www.zoetis.com/innovation/research-development and follow the instruction for submission. The application deadline is Feb. 28, 2018. Grant applications will be reviewed by a Zoetis committee composed of leaders from across divisions and disciplines. Candidates will be notified of the committee’s decision by March 31, 2018.

Source: Zoetis